(MSMP) Multi slice multiple phases is a cardiac gated sequence with different heart phases and several slices.
(SSMP) Single slice multiple phase is a cardiac gated sequence with different heart phases in one slice.

From Hitachi Medical Systems America Inc.;
Hitachi expanded its portfolio with the Echelon™ 1.5T. The MRI scanner combines a compact magnet and a scalable 8-channel RF system with high-performance gradients and slew rate to select short echo times, small field of views, high matrices and thin slices. Standard features of the Echelon MRI system include higher-order active shim, RAPID (parallel imaging for use on brain MRI, body, cardiovascular imaging, and orthopedic coils), multiple coil ports, and an advanced reconstruction engine.

From GE Healthcare;
GE Healthcare has added the Signa HDe 1.5T™, a compact MRI device at an affordable price to its family of MRI products. It has a single electronic cabinet that can be positioned inside the scanner room rather than in a separate equipment room. The Signa HDe 1.5T can be installed in the same physical location as 0.5T MRI systems with minimal construction costs. According to GE, the installation has been simplified to last only 7 days and has a 30 percent smaller footprint than a typical 1.5T system.
The 1.5T Signa™ HDe MRI system is substantially equivalent to the currently marketed GE 1.5T machines. The data acquisition system supports 1, 4, 8 independent receive channels and multiple independent coil elements per channel during a single acquisition series. The gradient specifications of HDe are lower than other GE Signa 1.5T MRI systems, but it can support clinical applications in cardiac and spectroscopy imaging.

A set of k-space lines collected in a specified order but not constituting a complete coverage of k-space, thus can be used in conjunction with all ultrafast MRI techniques. Several segmental acquisitions may need to be run for complete coverage of k-space. If these lines are recorded for a single rather than multiple images, imaging time can be shortened considerably maintaining an acceptable temporal resolution.
For example, rapidly acquiring eight k-space lines per segment after each trigger until 128 lines of k-space are acquired in 16 triggers, thus makes image acquisition of multiple cardiac phases or anatomical slices possible in a breath-hold.

Liver imaging can be performed with sonography, computed tomography (CT) and magnetic resonance imaging (MRI). Ultrasound is, caused by the easy access, still the first-line imaging method of choice; CT and MRI are applied whenever ultrasound imaging yields vague results. Indications are the characterization of metastases and primary liver tumors e.g., benign lesions such as focal nodular hyperplasia (FNH), adenoma, hemangioma and malignant lesions (cancer) such as hepatocellular carcinomas (HCC). The decision, which medical imaging modality is more suitable, MRI or CT, is dependent on the different factors. CT is less costly and more widely available; modern multislice scanners provide high spatial resolution and short scan times but has the disadvantage of radiation exposure.
With the introduction of high performance MR systems and advanced sequences the image quality of MRI for the liver has gained substantially. Fast spin echo or single shot techniques, often combined with fat suppression, are the most common T2 weighted sequences used in liver MRI procedures. Spoiled gradient echo sequences are used as ideal T1 weighted sequences for evaluating of the liver. The repetition time (TR) can be sufficiently long to acquire enough sections covering the entire liver in one pass, and to provide good signal to noise. The TE should be the shortest in phase echo time (TE), which provides strong T1 weighting, minimizes magnetic susceptibility effects, and permits acquisition within one breath hold to cover the whole liver. A flip angle of 80° provides good T1 weighting and less of power deposition and tissue saturation than a larger flip angle that would provide comparable T1 weighting.
Liver MRI is very dependent on the administration of contrast agents, especially when detection and characterization of focal lesions are the issues. Liver MRI combined with MRCP is useful to evaluate patients with hepatic and biliary disease.
Gadolinium chelates are typical non-specific extracellular agents diffusing rapidly to the extravascular space of tissues being cleared by glomerular filtration at the kidney. These characteristics are somewhat problematic when a large organ with a huge interstitial space like the liver is imaged. These agents provide a small temporal imaging window (seconds), after which they begin to diffuse to the interstitial space not only of healthy liver cells but also of lesions, reducing the contrast gradient necessary for easy lesion detection. Dynamic MRI with multiple phases after i.v. contrast media (Gd chelates), with arterial, portal and late phase images (similar to CT) provides additional information.
An additional advantage of MRI is the availability of liver-specific contrast agents (see also Hepatobiliary Contrast Agents). Gd-EOB-DTPA (gadoxetate disodium, Gadolinium ethoxybenzyl dimeglumine, EOVIST Injection, brand name in other countries is Primovist) is a gadolinium-based MRI contrast agent approved by the FDA for the detection and characterization of known or suspected focal liver lesions.
Gd-EOB-DTPA provides dynamic phases after intravenous injection, similarly to non-specific gadolinium chelates, and distributes into the hepatocytes and bile ducts during the hepatobiliary phase. It has up to 50% hepatobiliary excretion in the normal liver.
Since ferumoxides are not eliminated by the kidney, they possess long plasmatic half-lives, allowing circulation for several minutes in the vascular space. The uptake process is dependent on the total size of the particle being quicker for larger particles with a size of the range of 150 nm (called superparamagnetic iron oxide). The smaller ones, possessing a total particle size in the order of 30 nm, are called ultrasmall superparamagnetic iron oxide particles and they suffer a slower uptake by RES cells. Intracellular contrast agents used in liver MRI are primarily targeted to the normal liver parenchyma and not to pathological cells. Currently, iron oxide based MRI contrast agents are not marketed.
Beyond contrast enhanced MRI, the detection of fatty liver disease and iron overload has clinical significance due to the potential for evolution into cirrhosis and hepatocellular carcinoma. Imaging-based liver fat quantification (see also Dixon) provides noninvasively information about fat metabolism; chemical shift imaging or T2*-weighted imaging allow the quantification of hepatic iron concentration.

See also Abdominal Imaging, Primovistâ„¢, Liver Acquisition with Volume Acquisition (LAVA), T1W High Resolution Isotropic Volume Examination (THRIVE) and Bolus Injection.

For Ultrasound Imaging (USI) see Liver Sonography at Medical-Ultrasound-Imaging.com.